highperformr logo

Aarti Drugs Limited's Overview

Total employees775
HeadquartersMumbai
Founded1984

Aarti Drugs Limited (ADL) is a significant Indian pharmaceutical company, part of the esteemed Aarti Group of Industries. Established in 1984, ADL has emerged as a leading manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. The company boasts a strong global presence, exporting its products to over 100 countries worldwide. ADL is deeply committed to research and development to maintain its competitive edge, focusing on quality, affordability, and sustainability in healthcare. Their diverse product portfolio addresses various therapeutic segments, making them a key player in the global pharmaceutical market.

Where is Aarti Drugs Limited's Headquarters?

HQ Function

The Mumbai headquarters serves as the central command for corporate strategy, financial management, global sales and marketing initiatives, regulatory affairs, human resources, and overall administrative functions for Aarti Drugs Limited.

Notable Features:

The headquarters is situated within the Mahendra Industrial Estate, offering strategic access to Mumbai's business ecosystem and logistical networks. It features modern corporate office facilities designed to support its administrative and strategic operations.

Work Culture:

Aarti Drugs fosters a professional, quality-focused, and results-driven work culture typical of the pharmaceutical sector. Emphasis is placed on compliance with stringent industry standards, innovation, continuous learning, and collaborative teamwork to achieve business objectives.

HQ Significance:

The Mumbai headquarters is pivotal due to its location in India's financial capital, which facilitates national and international business dealings, access to a skilled talent pool, and proximity to key regulatory bodies and financial institutions.

Values Reflected in HQ: The headquarters' operations and environment likely reflect Aarti Drugs' core values such as integrity, a strong commitment to quality, customer focus, innovation in processes and products, and a sense of responsibility towards its employees, stakeholders, and the broader community.

Location:

Aarti Drugs Limited has established a robust global presence, exporting its wide range of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals to over 100 countries. Key markets include regions in Asia, Europe, Latin America, Africa, and North America. This global outreach is supported by a strong distribution network, consistent adherence to international quality standards (including certifications like USFDA, EU GMP, WHO GMP, KFDA), and active participation in global pharmaceutical trade shows and collaborations. Functions supported globally encompass international sales and marketing, global supply chain management, customer relationship management, and ensuring regulatory compliance for diverse international markets.

Street Address:

Mahendra Industrial Estate, Ground Floor, Plot No. 109-D, Road No. 29, Sion (East)

City:

Mumbai

State/Province:

Maharashtra

Country:

India

Aarti Drugs Limited's Global Presence

Tarapur, Maharashtra, India

Address: Plot No. N-198, M.I.D.C., Tarapur, Boisar, Dist. Palghar - 401506, Maharashtra, India (Example of one of their Tarapur units)

Serves as a major production hub in Western India, leveraging the industrial infrastructure of the Tarapur MIDC (Maharashtra Industrial Development Corporation) area. It supports both domestic and international market demands.

Sarigam, Gujarat, India

Address: Plot No. 901/1, 901/2, 902, GIDC, Sarigam – 396155, Dist. Valsad, Gujarat, India (Example of one of their Sarigam units)

Strategically located in the chemical industrial belt of Gujarat, benefiting from a robust industrial ecosystem, skilled labor, and port connectivity for efficient raw material sourcing and product export.

Navi Mumbai, Maharashtra, India

Address: Aarti Research & Technology Centre, Plot No. D-300, TTC Industrial Area, MIDC-Turbhe, Navi Mumbai - 400705, Maharashtra, India

Drives the company's long-term growth and competitiveness by fostering innovation and technological advancement in pharmaceutical sciences. Its location in Navi Mumbai provides access to a skilled scientific community and research infrastructure.

Buying Intent Signals for Aarti Drugs Limited

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Aarti Drugs Limited

As of April 2025, Aarti Drugs Limited' leadership includes:

Shri Prakash M. Patil - Chairman & Managing Director
Shri Harshit M. Savla - Joint Managing Director
Shri Uday M. Patil - Whole-Time Director
Shri Rashesh C. Gogri - Whole-Time Director
Shri Adhish P. Patil - Chief Financial Officer
Shri Vilas G. Gaikar - Whole-Time Director & Chief Operating Officer - Formulations
Ms. Priti P. Savla - Whole-Time Director

Investors of Aarti Drugs Limited

Aarti Drugs Limited has been backed by several prominent investors over the years, including:

Promoter & Promoter Group (Gogri Family, Patil Family, and related entities)
Nippon Life India Trustee Ltd - A/C Nippon India Small Cap Fund
HDFC Trustee Company Ltd - A/C HDFC Small Cap Fund
ICICI Prudential Life Insurance Company Limited
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Small Cap Fund
Government Pension Fund Global
Massachusetts Institute of Technology
Various Foreign Portfolio Investors (FPIs) and Domestic Institutional Investors (DIIs)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits2

In the past 12 months, Aarti Drugs Limited has experienced key transitions in its leadership, notably involving the Company Secretary & Compliance Officer role and the retirement of a Whole-Time Director. These changes are part of the company's standard corporate governance and succession planning processes.

Departures

Mr. Ajinkya S. Kulkarni, Mr. Ajinkya S. Kulkarni resigned from the post of Company Secretary & Compliance Officer effective November 10, 2023.
Mr. Bhaskar N. Thorat, Mr. Bhaskar N. Thorat retired as Whole-Time Director effective March 31, 2024, upon completion of his term.

New Appointments:

Ms. Snehal K. Kauthankar, Ms. Snehal K. Kauthankar was appointed as Company Secretary & Compliance Officer effective November 11, 2023.

Technology (Tech Stack) used by Aarti Drugs Limited

Discover the tools Aarti Drugs Limited uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Aarti Drugs Limited Email Formats and Examples

Aarti Drugs Limited, like many corporations, likely utilizes standardized email formats for its employees. While the exact formats can vary, common structures involve combinations of employee names and the company domain 'aartidrugs.com'. Understanding these patterns can be useful for professional communication.

Common email formats for Aarti Drugs Limited include `[first].[last]@aartidrugs.com` (e.g., jane.doe@aartidrugs.com) and `[first_initial][last]@aartidrugs.com` (e.g., jdoe@aartidrugs.com). The format `[first]@aartidrugs.com` (e.g. jane@aartidrugs.com) might also be used for some employees.

Format

prakash.patil@aartidrugs.com

Example

75%

Success rate

News and media

Business StandardMay 30, 2024

Aarti Drugs Q4 results: Net profit dips 19.3% YoY to Rs 56.50 crore

Aarti Drugs reported a 19.3% year-on-year decline in its consolidated net profit to Rs 56.50 crore for the quarter ended March 31, 2024. Revenue from operations also saw a decrease to Rs 662.09 crore from Rs 696.47 crore in the corresponding quarter of the previous year. The company cited challenging market conditions and pressure on input costs as factors impacting performance....more

MoneycontrolFebruary 14, 2024

Aarti Drugs Q3 PAT slips 18.6% to Rs 50.2 cr

Aarti Drugs Ltd reported an 18.6 percent year-on-year (YoY) fall in consolidated profit after tax (PAT) at Rs 50.2 crore for the quarter ended December 2023. Consolidated net sales for the quarter stood at Rs 636.05 crore, down 4.15 percent YoY....more

BSE India (Corporate Announcement)November 11, 2023

Aarti Drugs Appoints Ms. Snehal K. Kauthankar as Company Secretary and Compliance Officer

Aarti Drugs Limited informed the stock exchanges about the appointment of Ms. Snehal K. Kauthankar as the Company Secretary and Compliance Officer of the company, effective from November 11, 2023. This followed the resignation of Mr. Ajinkya S. Kulkarni from the said post....more

CARE RatingsJanuary 18, 2024

CARE Ratings Reaffirms Ratings for Aarti Drugs Limited's Bank Facilities

CARE Ratings reaffirmed the credit ratings for Aarti Drugs Limited's bank facilities. The long-term bank facilities were reaffirmed at CARE AA-; Stable, and short-term bank facilities at CARE A1+. The ratings continue to derive strength from the company's established market position, diversified product portfolio, and experienced management....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Aarti Drugs Limited, are just a search away.